000 01279 a2200337 4500
005 20250518074807.0
264 0 _c20200515
008 202005s 0 0 eng d
022 _a1468-2060
024 7 _a10.1136/annrheumdis-2019-216368
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSimpson, Rachel S
245 0 0 _aDupilumab as a novel steroid-sparing treatment for IgG4-related disease.
_h[electronic resource]
260 _bAnnals of the rheumatic diseases
_c04 2020
300 _a549-550 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aAsthma
_xcomplications
650 0 4 _aDermatitis, Atopic
_xcomplications
650 0 4 _aGlucocorticoids
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G4-Related Disease
_xcomplications
650 0 4 _aMale
650 0 4 _aMale Urogenital Diseases
_xdiagnostic imaging
650 0 4 _aRetroperitoneal Fibrosis
_xdiagnostic imaging
700 1 _aLau, Stephanie Ka Ching
700 1 _aLee, Jason Kihyuk
773 0 _tAnnals of the rheumatic diseases
_gvol. 79
_gno. 4
_gp. 549-550
856 4 0 _uhttps://doi.org/10.1136/annrheumdis-2019-216368
_zAvailable from publisher's website
999 _c30440342
_d30440342